| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/J.INTIMP.2010.08.023 |
| P953 | full work available at URL | https://api.elsevier.com/content/article/PII:S1567576910002778?httpAccept=text/plain |
| https://api.elsevier.com/content/article/PII:S1567576910002778?httpAccept=text/xml | ||
| P698 | PubMed publication ID | 20837170 |
| P5875 | ResearchGate publication ID | 46255148 |
| P50 | author | Renato A.S. Oliveira | Q60324625 |
| Roberto Luzzati | Q87868288 | ||
| P2093 | author name string | Eulalia Azevedo-Ximenes | |
| Rodolfo C. Garcia | |||
| P2860 | cites work | Interleukin-12 production by human alveolar macrophages is controlled by the autocrine production of interleukin-10 | Q22008724 |
| Induction of direct antimicrobial activity through mammalian toll-like receptors | Q24290864 | ||
| Cutting edge: role of Toll-like receptor 1 in mediating immune response to microbial lipoproteins | Q24300005 | ||
| Cancer chemotherapy reports | Q27710278 | ||
| Synthesis of 3-aryl-5-decapentyl-1,2,4-oxadiazoles possessing antiinflammatory and antitumor properties | Q28192847 | ||
| Nitric oxide modulates superoxide release and peroxynitrite formation in human blood vessels | Q28203124 | ||
| Interferon-γ: an overview of signals, mechanisms and functions | Q28207081 | ||
| Reproductive toxicity of lapachol in adult male Wistar rats submitted to short-term treatment | Q28297336 | ||
| Persistent Coxiella burnetii infection in mice overexpressing IL-10: an efficient model for chronic Q fever pathogenesis | Q28472141 | ||
| Lack of acidification in Mycobacterium phagosomes produced by exclusion of the vesicular proton-ATPase | Q29617355 | ||
| Immunological and inflammatory functions of the interleukin-1 family | Q29619669 | ||
| Pulmonary infections associated with non-tuberculous mycobacteria in immunocompetent patients | Q31155150 | ||
| Parameters determining the relative efficacy of hydroxy-naphthoquinone inhibitors of the cytochrome bc1 complex | Q33279892 | ||
| Mycobacterium smegmatis mc2 155 fbiC and MSMEG_2392 are involved in triphenylmethane dye decolorization and coenzyme F420 biosynthesis | Q33292126 | ||
| Role of quinones in toxicology. | Q33867937 | ||
| A novel polymorphism in the toll-like receptor 2 gene and its potential association with staphylococcal infection | Q34005032 | ||
| TNF regulates chemokine induction essential for cell recruitment, granuloma formation, and clearance of mycobacterial infection | Q34125021 | ||
| Cellular response to oxidative stress: signaling for suicide and survival | Q34138566 | ||
| NO reductase from Bacillus azotoformans is a bifunctional enzyme accepting electrons from menaquinol and a specific endogenous membrane-bound cytochrome c551. | Q34359851 | ||
| Uncovering the molecular mode of action of the antimalarial drug atovaquone using a bacterial system. | Q34499482 | ||
| Interleukin 10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via downregulation of class II major histocompatibility complex expression | Q34504988 | ||
| Molecular basis for atovaquone binding to the cytochrome bc1 complex | Q34534276 | ||
| Recent studies on natural products as anticancer agents. | Q35644599 | ||
| Immunological control of tuberculosis: role of tumour necrosis factor and more | Q36292624 | ||
| Identification of interferon-gamma as the lymphokine that activates human macrophage oxidative metabolism and antimicrobial activity | Q36348121 | ||
| Reprogramming of the macrophage transcriptome in response to interferon-gamma and Mycobacterium tuberculosis: signaling roles of nitric oxide synthase-2 and phagocyte oxidase | Q36369581 | ||
| New drug candidates and therapeutic targets for tuberculosis therapy | Q36396522 | ||
| Lung disease due to the more common nontuberculous mycobacteria | Q36508278 | ||
| Toll-like receptor-2 mediates mycobacteria-induced proinflammatory signaling in macrophages. | Q36746122 | ||
| Arginine metabolism: boundaries of our knowledge | Q36826863 | ||
| The expanding family of interleukin-1 cytokines and their role in destructive inflammatory disorders | Q36859216 | ||
| The macrophage: past, present and future | Q36986722 | ||
| Macrophage activation by endogenous danger signals | Q37045743 | ||
| Evidence for inhibition of fusion of lysosomal and prelysosomal compartments with phagosomes in macrophages infected with pathogenic Mycobacterium avium | Q37054237 | ||
| TLR2 - promiscuous or specific? A critical re-evaluation of a receptor expressing apparent broad specificity | Q37136130 | ||
| The bacterial respiratory nitric oxide reductase | Q37416193 | ||
| Glycopeptidolipids from Mycobacterium avium promote macrophage activation in a TLR2- and MyD88-dependent manner | Q39501716 | ||
| The beta-glucan receptor dectin-1 functions together with TLR2 to mediate macrophage activation by mycobacteria | Q39609889 | ||
| Control of mycobacterial replication in human macrophages: roles of extracellular signal-regulated kinases 1 and 2 and p38 mitogen-activated protein kinase pathways | Q39656080 | ||
| Characterization and investigation of single nucleotide polymorphisms and a novel TLR2 mutation in the human TLR2 gene | Q40149533 | ||
| Soluble forms of Toll-like receptor (TLR)2 capable of modulating TLR2 signaling are present in human plasma and breast milk | Q40609296 | ||
| Inhibitory effects of lapachol derivatives on epstein-barr virus activation | Q40676151 | ||
| The Toll-like receptor 2 is recruited to macrophage phagosomes and discriminates between pathogens. | Q40919510 | ||
| Mycobacterium-containing phagosomes are accessible to early endosomes and reflect a transitional state in normal phagosome biogenesis | Q41079034 | ||
| Probing binding determinants in center P of the cytochrome bc(1) complex using novel hydroxy-naphthoquinones | Q41767081 | ||
| Activation of human macrophages. Comparison of other cytokines with interferon-gamma | Q42232581 | ||
| Comparison of antibacterial and antifungal activities of lapachol and beta-lapachone. | Q42563308 | ||
| Hydroxylated naphthoquinones as substrates for Escherichia coli anaerobic reductases | Q42990586 | ||
| Cytokine profiles in immunocompetent persons infected with Mycobacterium avium complex | Q43807033 | ||
| The inducing role of tumor necrosis factor in the development of bactericidal granulomas during BCG infection | Q43831403 | ||
| In vitro antimicrobial activity of a new series of 1,4-naphthoquinones | Q44073055 | ||
| In vitro activity of Brazilian medicinal plants, naturally occurring naphthoquinones and their analogues, against methicillin-resistant Staphylococcus aureus | Q44361700 | ||
| Disparity in IL-12 release in dendritic cells and macrophages in response to Mycobacterium tuberculosis is due to use of distinct TLRs | Q44576601 | ||
| The Arg753GLn polymorphism of the human toll-like receptor 2 gene in tuberculosis disease | Q44773559 | ||
| Antimycobacterial constituents from Juniperus procera, Ferula communis and Plumbago zeylanica and their in vitro synergistic activity with isonicotinic acid hydrazide | Q45186165 | ||
| Diospyrone, crassiflorone and plumbagin: three antimycobacterial and antigonorrhoeal naphthoquinones from two Diospyros spp. | Q45977945 | ||
| Promotion or suppression of experimental metastasis of B16 melanoma cells after oral administration of lapachol | Q46737897 | ||
| Mycobacterial lipomannan induces MAP kinase phosphatase-1 expression in macrophages | Q46803793 | ||
| Trypanosoma cruzi: activities of lapachol and alpha- and beta-lapachone derivatives against epimastigote and trypomastigote forms | Q46889016 | ||
| Tumor necrosis factor blockers influence macrophage responses to Mycobacterium tuberculosis | Q47561672 | ||
| Nontuberculous mycobacteria in non-HIV patients: epidemiology, treatment and response | Q47973698 | ||
| Kinetic of RelA activation controls magnitude of TLR-mediated IL-12p40 induction. | Q51833319 | ||
| Oral toxicology studies with lapachol | Q53724988 | ||
| Relationship between inhibition of mitochondrial respiration by naphthoquinones, their antitumor activity, and their redox potential. | Q53733326 | ||
| Depressed T‐Cell Interferon‐γ Responses in Pulmonary Tuberculosis: Analysis of Underlying Mechanisms and Modulation with Therapy | Q58329499 | ||
| Induction of IL-1 , IL-6, TNF- , GM-CSF and G-CSF in human macrophages by smooth transparent and smooth opaque colonial variants of Mycobacterium avium | Q61320751 | ||
| Estrogen Up-regulates Apolipoprotein E (ApoE) Gene Expression by Increasing ApoE mRNA in the Translating Pool via the Estrogen Receptor α-Mediated Pathway | Q61658761 | ||
| Site of action of the antimalarial hydroxynaphthoquinone, 2-[trans-4-(4'-chlorophenyl) cyclohexyl]-3- hydroxy-1,4-naphthoquinone (566C80) | Q67487758 | ||
| Antiinflammatory action of lapachol | Q68861850 | ||
| Lapachol inhibition of vitamin K epoxide reductase and vitamin K quinone reductase | Q70666132 | ||
| The acute phase response | Q71618259 | ||
| Interleukin-10 inhibits antimicrobial activity against Leishmania major in murine macrophages | Q72751321 | ||
| Inhibition of IL-12 production in human monocyte-derived macrophages by TNF | Q73406955 | ||
| Antiplasmodial activity of naphthoquinones related to lapachol and beta-lapachone | Q79455247 | ||
| Cytotoxic and DNA-topoisomerase effects of lapachol amine derivatives and interactions with DNA | Q80830075 | ||
| The effects on Trypanosoma cruzi of novel synthetic naphthoquinones are mediated by mitochondrial dysfunction | Q84012103 | ||
| P433 | issue | 11 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 1463-1473 | |
| P577 | publication date | 2010-09-15 | |
| P1433 | published in | International Immunopharmacology | Q15751306 |
| P1476 | title | The hydroxy-naphthoquinone lapachol arrests mycobacterial growth and immunomodulates host macrophages | |
| P478 | volume | 10 |
| Q46313125 | Age-related cataracts: Role of unfolded protein response, Ca2+ mobilization, epigenetic DNA modifications, and loss of Nrf2/Keap1 dependent cytoprotection |
| Q45248130 | Anti-inflammatory and anti-arthritic activities of 3,4-dihydro-2,2-dimethyl-2H-naphthol[1,2-b]pyran-5,6-dione (β-lapachone). |
| Q38929936 | Non-cytochrome P450-mediated bioactivation and its toxicological relevance. |
Search more.